September 27th, 2010
Promising Results for New DES in Peripheral Disease
Larry Husten, PHD
A new drug-eluting stent designed to treat peripheral disease showed promising results in the largest trial yet of endovascular treatment in this population. The 12-month results of the Zilver PTX randomized trial comparing a novel paclitaxel-eluting stent versus balloon angioplasty and bare-metal stenting in patients with symptomatic above-the-knee femoropopliteal artery disease were presented at TCT2010 by Michael Dake. […]
NEJM Journal Watch — Recent Cardiology Articles- Which Patients with Cardiogenic Shock Are at Risk for Early Death?
- Cardiac Magnetic Resonance Imaging for Risk Stratification in Nonischemic Cardiomyopathy
- Evidence Mounts for Triple Single-Pill Combination Therapy for Hypertension
- Atherosclerosis Burden and Progression on Imaging and Associated Mortality in Asymptomatic Patients
- Native Hawaiian and Pacific Islander U.S. Adult Cardiovascular Mortality